Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism GGPS1 inhibitors(geranylgeranyl diphosphate synthase 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Multiple Myeloma | Preclinical | CA | 14 Dec 2023 | |
Pancreatic Ductal Adenocarcinoma | Preclinical | CA | 14 Dec 2023 |